Sandoz on March 22 issued a voluntary recall of 13 lots of oral orphenadrine citrate 100 mg extended release tablets because of possible elevated levels of a nitrosamine.
Read the full post on Becker's Hospital Review - Healthcare News
Sandoz recalls pain med over carcinogen
